Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

Published:2019-09 Issue:10202 Volume:394 Page:939-951
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Huhn Maximilian,Nikolakopoulou Adriani,Schneider-Thoma Johannes,Krause Marc,Samara Myrto,Peter Natalie,Arndt Thomas,Bäckers Lio,Rothe Philipp,Cipriani Andrea,Davis John,Salanti Georgia,Leucht Stefan

Funder

National Institute for Health Research

NIHR Oxford Health Biomedical Research Centre

German Ministry of Education and Research

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;Kassebaum;Lancet,2016

2. The economic burden of schizophrenia in the United States in 2013;Cloutier;J Clin Psychiatry,2016

3. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis;Leucht;Lancet,2013